Pages that link to "Q40940832"
Jump to navigation
Jump to search
The following pages link to An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine (Q40940832):
Displaying 50 items.
- Genetic variability among complete human respiratory syncytial virus subgroup A genomes: bridging molecular evolutionary dynamics and epidemiology (Q21133803) (← links)
- In Hot Pursuit of the First Vaccine Against Respiratory Syncytial Virus (Q26748856) (← links)
- Best practice in the prevention and management of paediatric respiratory syncytial virus infection (Q26749036) (← links)
- Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease (Q26775152) (← links)
- Vaccine Adjuvants: from 1920 to 2015 and Beyond (Q26783879) (← links)
- Systems biology from virus to humans (Q26798272) (← links)
- The use of humanized monoclonal antibodies for the prevention of respiratory syncytial virus infection (Q26864494) (← links)
- Respiratory syncytial virus infection in cattle (Q27014853) (← links)
- Recent vaccine development for human metapneumovirus (Q27023742) (← links)
- Replacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidates. (Q27469749) (← links)
- Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes (Q27668015) (← links)
- Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice (Q28730052) (← links)
- Immunopathology in RSV infection is mediated by a discrete oligoclonal subset of antigen-specific CD4(+) T cells. (Q30308165) (← links)
- Sensitive detection and quantitation of mouse eosinophils in tissues using an enzymatic eosinophil peroxidase assay: its use to rapidly measure pulmonary eosinophilia during experimental respiratory syncytial virus infection of mice (Q30309276) (← links)
- Chemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatment (Q30368920) (← links)
- Pulmonary eosinophilia is attenuated by early responding CD8(+) memory T cells in a murine model of RSV vaccine-enhanced disease (Q30435871) (← links)
- Fas ligand is required for the development of respiratory syncytial virus vaccine-enhanced disease (Q30436942) (← links)
- The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia. (Q30437797) (← links)
- The stability of human respiratory syncytial virus is enhanced by incorporation of the baculovirus GP64 protein (Q30440686) (← links)
- Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus (Q30441455) (← links)
- Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV (Q30448968) (← links)
- Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG. (Q30485791) (← links)
- Whither vaccines? (Q30829948) (← links)
- RSV vaccine use--the missing data. (Q31030277) (← links)
- Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus (Q33323372) (← links)
- Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology (Q33558475) (← links)
- Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment (Q33588916) (← links)
- Intranasal antibody prophylaxis for protection against viral disease. (Q33683058) (← links)
- Adherence to Immunoprophylaxis Regimens for Respiratory Syncytial Virus Infection in Insured and Medicaid Populations (Q33705088) (← links)
- Respiratory syncytial virus infection (Q33732334) (← links)
- Pharmacologic advances in the treatment and prevention of respiratory syncytial virus (Q33776507) (← links)
- Priming with Secreted Glycoprotein G of Respiratory Syncytial Virus (RSV) Augments Interleukin-5 Production and Tissue Eosinophilia after RSV Challenge (Q33783066) (← links)
- Cytotoxic T-lymphocyte precursor frequencies in BALB/c mice after acute respiratory syncytial virus (RSV) infection or immunization with a formalin-inactivated RSV vaccine (Q33785332) (← links)
- Mucosal vaccines against respiratory syncytial virus (Q33837530) (← links)
- Immunology of Varicella Immunization in the elderly (Q33838926) (← links)
- Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge (Q33849224) (← links)
- Respiratory Syncytial Virus: A Prioritized or Neglected Target? (Q33852442) (← links)
- Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model (Q33887642) (← links)
- A step ahead. Infant protection through maternal immunization (Q33889592) (← links)
- Respiratory syncytial virus infections in infants affected by primary immunodeficiency. (Q33892605) (← links)
- Immunization of pediatric solid organ transplant candidates and recipients (Q33942411) (← links)
- Prevention and treatment of respiratory syncytial virus and parainfluenza viruses in immunocompromised patients (Q33950838) (← links)
- Respiratory syncytial virus vaccines (Q33975330) (← links)
- Efficacy of RD3-0028 aerosol treatment against respiratory syncytial virus infection in immunosuppressed mice. (Q33976579) (← links)
- Heterologous immunity between viruses (Q34051846) (← links)
- Intramuscular inoculation of live respiratory syncytial virus induces immunity in cotton rats (Q34080111) (← links)
- Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors (Q34082711) (← links)
- Bound immunoglobulin and foreign antigen in lungs of sudden infant death syndrome victims (Q34086558) (← links)
- Respiratory syncytial virus infection in owl monkeys: viral shedding, immunological response, and associated illness caused by wild-type virus and two temperature-sensitive mutants (Q34100392) (← links)
- Increased influenza pneumonia mortality of mice adoptively immunized with node and spleen cells sensitized by inactivated but not live virus (Q34119189) (← links)